There are also studies that have evaluated the feasibility of intraoperative FRα-targeted tumor detection with pafolacianine in other types of cancers, such as endometrial cancer and pulmonary osteosarcoma metastases [92,93]. This evidence concerns the gene FOLR1 and endometrial cancer.